Log in to save to my catalogue

Pityriasis Rosea in a Hepatitis B-Positive Patient Treated with Pegylated Interferon α2a: Report of...

Pityriasis Rosea in a Hepatitis B-Positive Patient Treated with Pegylated Interferon α2a: Report of...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_24335203

Pityriasis Rosea in a Hepatitis B-Positive Patient Treated with Pegylated Interferon α2a: Report of a Case and Review of the Literature

About this item

Full title

Pityriasis Rosea in a Hepatitis B-Positive Patient Treated with Pegylated Interferon α2a: Report of a Case and Review of the Literature

Publisher

Basel, Switzerland

Journal title

Dermatology (Basel), 2014, Vol.228 (1), p.10-13

Language

English

Formats

Publication information

Publisher

Basel, Switzerland

More information

Scope and Contents

Contents

Pityriasis rosea (PR) is an acute, self-limiting exanthematous disease caused by the endogenous reactivation of human herpesvirus (HHV)-6 and/or HHV-7 infection in conditions of altered immunity. In addition, many drugs have been incriminated as possible triggers of PR-like eruptions, characterized by clinical, morphological and histopathological f...

Alternative Titles

Full title

Pityriasis Rosea in a Hepatitis B-Positive Patient Treated with Pegylated Interferon α2a: Report of a Case and Review of the Literature

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_24335203

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_24335203

Other Identifiers

ISSN

1018-8665

E-ISSN

1421-9832

DOI

10.1159/000356176

How to access this item